Judgment of the Swiss Federal Supreme Court on the VAT liability of sports betting has become legally binding ...
Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on macrocycle therapeutics for rare diseases and oncology, today announced that it expects the Swiss SIX exchange to ...
GENEVA (NOV. 4, 2024) – RELIEF THERAPEUTICS Holding SA (SIX: RLF, OTCQB: RLFTF, RLFTY) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options ...
LEG subsidiary and Adler Real Estate GmbH (Adler) enter into share purchase agreement regarding 52.68% of the shares in Brack Capital Properties N.V. (BCP) Adler commits to tender additional 10.1% ...
The previous forecast of bet-at-home.com AG (hereinafter also referred to as the "BaH") assumed that bet-at-home.com AG Group will achieve in the financial year 2024 a gross betting and gaming revenue ...
Third-quarter revenue amounted to CHF 585.5 million, a strong increase of 11.2% organic growth, bringing revenue in the first nine months to about CHF 1.9 billion Global launch of intraoral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback